About the Author
Markus J Seibel, MD PhD FRACP FAHMS, is Professor of Endocrinology at Sydney University. He is the Inaugural Director of the Bone Research Program at the ANZAC Research Institute, and heads the Department of Endocrinology & Metabolism at Concord Hospital, Sydney. His research in musculoskeletal biology covers topics such as glucocorticoid signalling in bone and its effects on bone and systemic fuel metabolism and ageing; the biology of bone metastases; and the clinical efficacy of secondary fracture prevention programs. Prof Seibel has published over 400 scientific papers and is the editor of 8 books. In 2017, he has been elected to the Australian Academy of Health and Medical Sciences. Prof Seibel is a Past President of the Australia and New Zealand Bone & Mineral Society (ANZBMS), a Member of the Board of Directors, International Federation of Musculoskeletal Research Societies (IFMRS), and the Chair of the Australian National Alliance for Secondary Fracture Prevention. Dr. Mitchell is the Managing Director at Synthesis Medical NZ Limited. His primary goal is to improve management of chronic disease by closing care gaps through systematic implementation of evidence-based practice.Dr. Mitchell has spent the last decade developing policy, guidelines and systematic approaches to hip fracture care and prevention throughout the world. He spent the previous 15 years working in the pharmaceutical industry, initially as a basic researcher in neuroscience and, subsequently, in sales, marketing and osteoporosis service development roles.Specialties: Systems-based approaches to chronic disease management, osteoporosis, fragility fracture prevention, orthogeriatrics, fracture registries, dementia care, policy development, literature review, medical education, website content development.